Nasal Allergy News and Research

RSS
Tips for combating fall allergies

Tips for combating fall allergies

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Guidelines to help people with allergies during bad weather

Guidelines to help people with allergies during bad weather

Internet may foresee height of allergy suffering

Internet may foresee height of allergy suffering

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

FDA approves Teva's QNASL nasal aerosol corticosteroid

FDA approves Teva's QNASL nasal aerosol corticosteroid

AAFA releases new 'Spring Allergy Capital' rankings

AAFA releases new 'Spring Allergy Capital' rankings

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

Tips for preventing allergy during ragweed pollen season

Tips for preventing allergy during ragweed pollen season

Survey: AR symptoms continue to impact patients' daily activities

Survey: AR symptoms continue to impact patients' daily activities

Stink bugs may worsen asthma, cause allergy

Stink bugs may worsen asthma, cause allergy

Merck reports GAAP net income of $861 million for 2010

Merck reports GAAP net income of $861 million for 2010

Merck reports $342 million net income for 2010 third quarter

Merck reports $342 million net income for 2010 third quarter

Merck reports strong bottom-line performance in second quarter

Merck reports strong bottom-line performance in second quarter

Sepracor announces preliminary results from OMNARIS HFA Phase III study for seasonal allergic rhinitis

Sepracor announces preliminary results from OMNARIS HFA Phase III study for seasonal allergic rhinitis

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

ISTA Pharmaceuticals first-quarter net revenues up 39%

ISTA Pharmaceuticals first-quarter net revenues up 39%

Merck announces global sales of $27.4 billion for full-year 2009

Merck announces global sales of $27.4 billion for full-year 2009

New study suggests nasal allergy may be involved in chronic sinus disease

New study suggests nasal allergy may be involved in chronic sinus disease